Pages that link to "Q79849459"
Jump to navigation
Jump to search
The following pages link to Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin (Q79849459):
Displaying 27 items.
- Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism (Q24603957) (← links)
- Modulation of h(2)s metabolism by statins: a new aspect of cardiovascular pharmacology (Q27001076) (← links)
- Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content (Q27305332) (← links)
- Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? (Q28075647) (← links)
- Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (Q28083004) (← links)
- Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise (Q28086884) (← links)
- Polymorphisms in the mitochondrial ribosome recycling factor EF-G2mt/MEF2 compromise cell respiratory function and increase atorvastatin toxicity (Q28480419) (← links)
- Dietary supplementation with essential amino acids boosts the beneficial effects of rosuvastatin on mouse kidney (Q34045750) (← links)
- Evaluation of skeletal muscle during calf exercise by 31‐phosphorus magnetic resonance spectroscopy in patients on statin medications (Q34155702) (← links)
- Improvement in sleep apnoea associated with switch from simvastatin to pravastatin (Q34532922) (← links)
- Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase (Q34579854) (← links)
- Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study. (Q34609795) (← links)
- Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia (Q36139098) (← links)
- Skeletal muscle metabolic adaptations to endurance exercise training are attainable in mice with simvastatin treatment (Q36282975) (← links)
- Molecular mechanisms of statin intolerance (Q36958324) (← links)
- High-dose statin use does not impair aerobic capacity or skeletal muscle function in older adults (Q36979363) (← links)
- Simvastatin impairs exercise training adaptations (Q37100826) (← links)
- Intolerance to statins: mechanisms and management (Q37577161) (← links)
- The effects of statin medications on aerobic exercise capacity and training adaptations. (Q38228143) (← links)
- Statins, Muscle Disease and Mitochondria (Q41552418) (← links)
- Coenzyme Q(10) and statin myalgia: what is the evidence? (Q42931503) (← links)
- An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells. (Q52733697) (← links)
- Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications (Q84286421) (← links)
- Endurance exercise increases the protein levels of PGC-1α and respiratory chain complexes in mouse skeletal muscle during atorvastatin administration (Q90396446) (← links)
- Sources of Inter-individual Variability in the Therapeutic Response of Blood Glucose Control to Exercise in Type 2 Diabetes: Going Beyond Exercise Dose (Q90649939) (← links)
- Mitochondrial disorders and drugs: what every physician should know (Q92485483) (← links)
- Statin-Associated Cardiomyopathy Responds to Statin Withdrawal and Administration of Coenzyme Q10 (Q93184041) (← links)